CP 532623
|
|
- CAS号:
- 261947-38-0
- 英文名:
- (2R,4S)-4-[Acetyl[[3,5-bis(trifluoromethyl)phenyl]methyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-1(2H)-quinolinecarboxylic acid 1-methylethyl ester
- 英文别名:
- CP 532623;CP532623,CP 532623;CP 532623 >=98% (HPLC);(2R,4S)-4-[Acetyl[[3,5-bis(trifluoromethyl)phenyl]methyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-1(2H)-quinolinecarboxylic acid 1-methylethyl ester;1(2H)-Quinolinecarboxylic acid, 4-[acetyl[[3,5-bis(trifluoromethyl)phenyl]methyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, 1-methylethyl ester, (2R,4S)-
- 中文名:
- CP 532623
- 中文别名:
- 化合物 T15004
- CBNumber:
- CB62750378
- 分子式:
- C27H27F9N2O3
- 分子量:
- 598.5
- MOL File:
- 261947-38-0.mol
|
|
|
CP 532623化学性质
-
熔点:
-
101.8 °C
-
|
-
沸点:
-
523.8±50.0 °C(Predicted)
-
|
-
密度:
-
1.38±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
2-8°C
-
|
-
溶解度:
-
DMSO: soluble20mg/mL, clear
-
|
-
形态:
-
powder
-
|
-
酸度系数(pKa):
-
-0.93±0.40(Predicted)
-
|
-
颜色:
-
white to beige
-
|
CP 532623性质、用途与生产工艺
CP-532623 是 CETP 抑制剂,可提高高密度脂蛋白胆固醇水平。CP-532623 与 Torcetrapib 的结构相似,并具有高度亲脂性。
CP-532623 is highly lymphatically transported (28% of dose), and lymphatic transport is closely correlated with drug affinity for ex-vivo lymph lipoproteins or triglyceride emulsions and poorly relates to solubility in mixtures of lipoprotein core and/or surface lipids. CP-532623 alters the kinetics of lymph lipid transport and decreases lymph lipid transport in chylomicrons.
CP-532623 (50 mg; oral administration; adult male greyhound dogs) treatment substantially transports into the lymphatic system (>25% dose) in fed and fasted dogs. Food enhances oral bioavailability (from 44 to 58%, respectively) and the proportion of the absorbed dose transports via the lymph (from 61 to 86% and from 68 to 83%, respectively). Lymphatic triglyceride transport is significantly lower in fed dogs administered CP-532623.
Animal Model:
|
Adult male greyhound dogs (27-39 kg)
|
Dosage:
|
50 mg
|
Administration:
|
Oral administration with a long-chain lipid formulation to fed lymphcannulated
|
Result:
|
Substantially transported into the lymphatic system (>25% dose) in fed and fasted dogs. Food enhanced oral bioavailability and the proportion of the absorbed dose transported via the lymph.
|
CP 532623
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | HY-123039 | CP 532623 CP-532623 | 261947-38-0 | 5mg | 2160元 |
2024/01/25 | HY-123039 | CP-532623 | | 1 mg | 2090元 |
261947-38-0, CP 532623 相关搜索:
- C27H27F9N2O3
- 化合物 T15004
- 261947-38-0
- CP532623,CP 532623
- CP 532623 >=98% (HPLC)
- 1(2H)-Quinolinecarboxylic acid, 4-[acetyl[[3,5-bis(trifluoromethyl)phenyl]methyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, 1-methylethyl ester, (2R,4S)-
- CP 532623
- (2R,4S)-4-[Acetyl[[3,5-bis(trifluoromethyl)phenyl]methyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-1(2H)-quinolinecarboxylic acid 1-methylethyl ester